NCT06299527

Brief Summary

Sixty-six FMS patients received the same exercise program for 8 weeks and divided, synchronous (n: 33), asynchronous (n: 33). Pain (Visual analog Scale, VAS), functional limitations and disabilities (Revised Fibromyalgia Impact Questionnaire, FEA), health-related quality of life (HRQol; Short Form-12, SF 12), catastrophizing (pain catastrophizing scale, PCS), anxiety and depression (Hospital Anxiety and Depression Scale, HAD), functional capacity (6-minute walking test, 6MWT), muscle strength (Arm curl test) joint position sense (Laser Cursor Assisted Angle Repetition Test, LI-RATT) were assessed at baseline, mid-treatment (week 4), end of treatment (week 8), and eight weeks after treatment (week 16).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 27, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 27, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 1, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 8, 2024

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

March 1, 2024

Last Update Submit

March 11, 2024

Conditions

Keywords

FibromyalgiaTelerehabilitationMobile health

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale

    A visual analog scale was used to evaluate the patient's pain. This scale is used to quantify pain intensity that cannot be measured numerically. Numbers are written on the two ends of a 10 cm line. The patient is asked to indicate on this line where the pain condition is appropriate during rest by drawing a line, putting a dot or pointing. For pain intensity, according to the scale, "no pain" will be rated as 0 points and "worst pain imaginable" as 10 points. The ranges for pain intensity were determined as \<3 Mild pain, 3-6 moderate pain, 6 and above severe pain.

    at baseline at mid-treatment (week 4), at the end of treatment (week 8), and eight weeks after treatment (week 16)

Secondary Outcomes (7)

  • Revised Fibromyalgia Impact Questionnaire

    at baseline at mid-treatment (week 4), at the end of treatment (week 8), and eight weeks after treatment (week 16)

  • Pain Catastrophizing Scale

    at baseline at mid-treatment (week 4), at the end of treatment (week 8), and eight weeks after treatment (week 16)

  • Hospital Anxiety and Depression Scale

    at baseline at mid-treatment (week 4), at the end of treatment (week 8), and eight weeks after treatment (week 16)

  • 6 Minute Walk Test

    at baseline at mid-treatment (week 4), at the end of treatment (week 8), and eight weeks after treatment (week 16)

  • Arm Curl Test

    at baseline at mid-treatment (week 4), at the end of treatment (week 8), and eight weeks after treatment (week 16)

  • +2 more secondary outcomes

Study Arms (2)

Synchronous Exercise Group

EXPERIMENTAL

Synchronous telerehabilitation was performed via videoconference. Patients were taken to video conference calls accompanied by a researcher and supervisor. Participants were to perform their exercises simultaneously under the guidance of the researcher. Participants were taken to video conference calls in groups of 5 with similar functional levels. Each session lasts an average of 45 minutes. It was last. The start and end date of the exercise program, the number of repetitions for each exercise, the number of sets, daily repetitions, rest time between sets and the order of the exercises were determined by the researcher.

Other: Exercise Program

Asynchronous Exercise Group

ACTIVE COMPARATOR

Asynchronous telerehabilitation was carried out through the mobile application. Researchers created a record for each participant in the mobile application with the personal information of the participants. Participants were logged in to the application with an account address and password created for them. The mobile application was supervised and followed by a researcher. The principal researcher prepared an exercise program specifically for each participant. He sent the exercise program he had prepared to the relevant participants through the application. In the mobile application, all exercises are explained in video and writing.

Other: Exercise Program

Interventions

Exercise Program In our study, the telerehabilitation program was applied for both synchronous and asynchronous groups, 3 days a week, 1 session per day, for 8 weeks. The exercises were combined individually according to the person's capacity, and the intensity and duration of the exercise will gradually increase according to the patient's tolerance.

Asynchronous Exercise GroupSynchronous Exercise Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with FMS by the physician in accordance with ACR 2016 criteria,
  • Having independent mobility,
  • Not having advanced vision and hearing loss,
  • Minimum literacy, participating voluntarily, making video calls, Internet and smartphone access

You may not qualify if:

  • Have a rheumatic disease with more prominent symptoms than FMS,
  • Have an active infection,
  • Have a surgical operation in the last three months,
  • Have an uncontrollable chronic disease,
  • Have another musculoskeletal disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health Sciences

Istanbul, Maltepe, 1464185881, Turkey (Türkiye)

Location

Related Publications (6)

  • BALKE B. A SIMPLE FIELD TEST FOR THE ASSESSMENT OF PHYSICAL FITNESS. REP 63-6. Rep Civ Aeromed Res Inst US. 1963 Apr:1-8. No abstract available.

    PMID: 14131272BACKGROUND
  • Soylu C, Kütük B. "Reliability and validity study of the Turkish form of the SF-12 Quality of Life Scale." Turkish Journal of Psychiatry.2020; 1-9.

    BACKGROUND
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

    PMID: 6880820BACKGROUND
  • Sullivan MJ, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychological assessment. 1995; 7(4): 524.

    BACKGROUND
  • Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10.

    PMID: 19664287BACKGROUND
  • Timurtas E, Huzmeli I, Demirbuken I, Polat MG. Clinical outcomes of asynchronous telerehabilitation through a mobile app are equivalent to synchronous telerehabilitation in patients with fibromyalgia: a randomized control study. BMC Musculoskelet Disord. 2025 Feb 4;26(1):118. doi: 10.1186/s12891-025-08377-6.

MeSH Terms

Conditions

Fibromyalgia

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

March 1, 2024

First Posted

March 8, 2024

Study Start

May 27, 2023

Primary Completion

November 15, 2023

Study Completion

January 27, 2024

Last Updated

March 13, 2024

Record last verified: 2024-03

Locations